BioRender is thrilled to be a part of the action at the ASCO Annual Meeting in Chicago on June 1-3. 🧑🔬 If you’re here, come find us at booth #30143! We'd love to meet you to talk about trends in oncology research and share best practices for visualizing your work. #ASCO24
BioRender’s Post
More Relevant Posts
-
HiRO's integration with Courante ushers in enhanced flexibility, personalized oncology service, and regional monitoring advantages. Add to this accelerated study start-ups and a personal dedication to oncology, the global HiRO team are changing the traditional CRO model. 🔗 Discover the holistic benefits of our combined approach. https://lnkd.in/gMnGa44r #ClientCentric #HolisticResearch #HiROxCourante #clinicaltrials #ClinicalResearch #drugdevelopment
-
-
A new ASCO policy statement is emphasizing the urgent need for global equity in #ClinicalTrials. In the statement, which published today in JCO Global Oncology, authors explain how global equity can be advanced by: •Diversifying trial representation •Increasing access to resources •Strengthening research capacity on a global scale. Learn more: https://brnw.ch/21wHSTn #ASCOHealthEquity
-
-
What a great read on the latest changes in the EU regulatory landscape! Find out the key programs and solutions that will play a significant role in oncology research in the future: https://bit.ly/3ychELe
-
-
REMINDER: Don't miss our upcoming webinar on December 5, "Unleashing the Power of Real-World Clinico-Genomic Data in Advancing Precision Oncology," featuring Emily L Paul and Suzzette Arnal. Learn more and register at the link below! #ClinicoGenomics #PrecisionOncology #CGP
-
#DCTs expand options for trial participants, but they also introduce more challenges for complex research, such as oncology trials. How can you ensure you have the right support for your hybrid trial? Find out in our blog. https://ow.ly/EjIR50Qzrgm #clinicalresearch #clinicaltrials
-
-
Hear the Inizio Medical Oncology experts summarize the key findings from ASCO on June 27th
Don’t miss our Key Findings and Missed Gems webinar from #ASCO24! 🚀 We're thrilled to have Will Fazzone join the webinar to discuss The ADC Landscape 2024. 🧬✨ This talk will cover: - Promising new ADC platforms and targets. - Clinical trial results for next-generation ADCs. - The outlook for ADC therapy. Don’t miss this chance to learn about cutting-edge advancements in oncology. Register here: https://lnkd.in/eiZYgQi9 #ASCO24 #Webinar #InizioMedical
-
-
Satej Bhogill and Catherine Chintala, PMP share what they enjoyed most at this year's #ASCO24 conference. Learn more about MERIT's oncology experience and solutions at https://lnkd.in/gD7rC9zQ #MERITCRO #YourClinicalEndpointExpert #imagingsolutions #clinicaltrials #clincialresearch #oncologytrials
-
In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech
Patient-guided oncology trials: Why the patient perspective is essential to success :: Parexel
share.parexel.social
